ACHV
Achieve Life Sciences IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$227.34M
P/E Ratio
—
EPS
$-1.25
Beta
1.96
52W High
$6.03
52W Low
$2.00
50-Day MA
$3.94
200-Day MA
$3.90
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
35.34
PEG Ratio
17.68
About Achieve Life Sciences Inc
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and markets cytisinicline for smoking and nicotine addiction cessation in the United States and internationally. The company is headquartered in Vancouver, Canada.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-54.65M |
| Operating Margin | 0.00% |
| Return on Equity | -257.70% |
| Return on Assets | -85.30% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.40 |
| Price-to-Book | 10.56 |
| Price-to-Sales (TTM) | 5.09 |
| EV/Revenue | 0.625 |
| EV/EBITDA | -2.42 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $53.24M |
| Float | $42.18M |
| % Insiders | 4.37% |
| % Institutions | 117.02% |
Historical Volatility
HV 10-Day
194.21%
HV 20-Day
136.55%
HV 30-Day
155.89%
HV 60-Day
116.02%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($14.56 target)
2
Strong Buy5
BuyData last updated: 4/29/2026